UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037335
Receipt number R000042561
Scientific Title Efficacy and safety of Movicol in combination with or after switching from the existing therapy in patients with chronic constipation (Retrospective observation research)
Date of disclosure of the study information 2019/07/11
Last modified on 2019/12/23 17:10:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of Movicol in combination with or after switching from the existing therapy in patients with chronic constipation(Retrospective observation research)

Acronym

Efficacy and safety of Movicol in combination with or after switching from the existing therapy in patients with chronic constipation(Retrospective observation research)

Scientific Title

Efficacy and safety of Movicol in combination with or after switching from the existing therapy in patients with chronic constipation (Retrospective observation research)

Scientific Title:Acronym

Efficacy and safety of Movicol in combination with or after switching from the existing therapy in patients with chronic constipation (Retrospective observation research)

Region

Japan


Condition

Condition

Chronic constipation

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine efficacy and safety of Movicol in combination with or after switching from the existing therapy (magnesium oxide, etc.) in patients with chronic constipation with inadequate response to the existing therapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of CSS total score between baseline and at Week 4 of administration

Key secondary outcomes

JPAC-QOL score
CSS total score (of each evaluation time point from baseline to Week 8)
CSS sub score (at each evaluation time point from baseline to Week 8)
Bristol Stool Form Scale


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed with chronic constipation and assessed as inadequate responders to the existing therapy (magnesium oxide, etc.)
2) Patients with 20 years or older at baseline
3) Patients receiving Movicol during the investigation period
4) Patients receiving the existing therapy (magnesium oxide, etc.) from more than 2 weeks before administration of Movicol

Key exclusion criteria

1) Patients who are suspected constipation due to organic disease
2) Patients with a history of hypersensitivity to any ingredients of Movicol
3) Patients who are confirmed or suspected intestinal obstruction, intestinal perforation, or severe inflammatory bowel disease (ulcerative colitis, Crohn's disease, toxic megacolon, etc.)

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takafumi
Middle name
Last name Maeda

Organization

TSUJINAKA HOSPITAL KASHIWANOHA

Division name

Coloprocrology

Zip code

277-0871

Address

148 Block 6 of the Kashiwanoha Campus,178-2,Wakashiba, Kashiwa, Chiba

TEL

04-7137-3737

Email

takafumisachiyo@yahoo.co.jp


Public contact

Name of contact person

1st name Takafumi
Middle name
Last name Maeda

Organization

TSUJINAKA HOSPITAL KASHIWANOHA

Division name

Coloprocrology

Zip code

277-0871

Address

148 Block 6 of the Kashiwanoha Campus,178-2,Wakashiba, Kashiwa, Chiba

TEL

04-7137-3737

Homepage URL


Email

takafumisachiyo@yahoo.co.jp


Sponsor or person

Institute

TSUJINAKA HOSPITAL KASHIWANOHA

Institute

Department

Personal name



Funding Source

Organization

EA Pharma Co., LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Joint Ethical Review Board

Address

1-14, Minamikubo, Kochi City, Kochi Prefecture

Tel

042-648-5551

Email

godou-irb@epsogo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団康喜会 辻仲病院柏の葉


Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

67

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 06 Day

Date of IRB

2019 Year 06 Month 24 Day

Anticipated trial start date

2019 Year 06 Month 06 Day

Last follow-up date

2019 Year 07 Month 11 Day

Date of closure to data entry


Date trial data considered complete

2019 Year 07 Month 31 Day

Date analysis concluded

2019 Year 08 Month 20 Day


Other

Other related information

Comparison of the total constipation scoring system (CSS) score at baseline and Week 4


Management information

Registered date

2019 Year 07 Month 11 Day

Last modified on

2019 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042561


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name